KALVISTA PHARMACEUTICALS INC (KALV) Stock Income Statement
USA - NASDAQ:KALV - US4834971032 - Common Stock
14.86 USD
+1.24 (+9.1%)
14.84 USD
-0.02 (-0.13%)
| 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 12.69M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 140.44M | 110.87M | 96.61M | 57.92M | 53.22M | |||
| Research and Development | 86.17M | 80.28M | 70.17M | 41.29M | 40.19M | |||
| Selling, General, and Administrative Expenses | 54.28M | 30.60M | 26.45M | 16.64M | 13.03M | |||
| Operating Income | -140.44M | -110.87M | -96.61M | -57.92M | -40.53M | |||
| Interest Income/Expense | 5.36M | 2.18M | 150.00K | 1.95M | 1.76M | |||
| Other Income/Expense | 8.44M | 15.78M | 14.12M | 9.73M | 9.53M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -126.64M | -92.91M | -82.34M | -46.24M | -29.24M | |||
| Income Tax | 0 | 0 | 0 | 0 | -120.00K | |||
| Net Income | -126.64M | -92.91M | -82.34M | -46.24M | -29.12M | |||
| EBITDA | -139.63M | -110.15M | -96.05M | -57.38M | -40.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.4427 | -3.33 | -3.36 | -2.42 | -1.64 | |||
| Non GAAP EPS | -3.4000000000000004 | -3.36 | -3.3600000000000003 | -2.4 | -1.64 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -229.47% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -319.39% | |||
All data in USD